Valuation: HANDOK Inc.

Market Cap 87.04B 56.75M 49.76M 45.87M 42.94M 80.53M 5.35B 82.2M 551M 213M 2.65B 213M 208M 9.18B P/E 2024
-3.16x
P/E 2025 -69x
Enterprise Value 438B 285M 250M 231M 216M 405M 26.91B 413M 2.77B 1.07B 13.3B 1.07B 1.05B 46.12B EV / Sales 2024
0.95x
EV / Sales 2025 0.93x
Free-Float
52.16%
Yield 2024
1.66%
Yield 2025 -
1 day-2.19%
1 week-14.10%
Current month-20.33%
1 month-27.25%
3 months-37.09%
6 months-41.23%
Current year-40.18%
1 week 6,470
Extreme 6470
7,700
1 month 6,470
Extreme 6470
8,900
Current year 6,470
Extreme 6470
11,820
1 year 6,470
Extreme 6470
13,460
3 years 6,470
Extreme 6470
20,300
5 years 6,470
Extreme 6470
28,450
10 years 6,470
Extreme 6470
44,750
Manager TitleAgeSince
Chief Executive Officer 69 -
Chief Executive Officer 68 1995-12-31
Director of Finance/CFO 58 -
Director TitleAgeSince
Chairman 68 1995-12-31
Director/Board Member 69 -
Director/Board Member 58 -
Change 5-day change 1-year change 3-year change Capi.($)
-2.19%-14.10%-42.83%-53.15% 57.76M
+6.97%+9.55%+51.84%+166.66% 1,006B
+3.56%+9.60%+66.81%+54.97% 589B
+1.52%+7.17%+31.97%+82.67% 430B
-0.66%+5.11%+29.26%+21.27% 331B
+1.82%+8.19%+41.15%+26.80% 288B
+0.22%+6.75%+31.51%+42.02% 285B
+0.73%+8.53%-26.22%-40.85% 213B
+1.03%+3.41%+27.72%+58.63% 190B
+2.45%+1.51%+17.78%+65.56% 154B
Average +1.43%+4.38%+22.90%+42.46% 348.58B
Weighted average by Cap. +3.01%+5.38%+39.64%+78.83%

Financials

2024 2025
Net sales 507B 331M 290M 267M 250M 469M 31.21B 479M 3.21B 1.24B 15.42B 1.24B 1.22B 53.48B 535B 349M 306M 282M 264M 495M 32.92B 505M 3.39B 1.31B 16.27B 1.31B 1.28B 56.41B
Net income -52.56B -34.27M -30.05M -27.7M -25.93M -48.63M -3.23B -49.64M -333M -129M -1.6B -129M -126M -5.54B -2.15B -1.4M -1.23M -1.13M -1.06M -1.99M -132M -2.03M -13.64M -5.28M -65.45M -5.27M -5.16M -227M
Net Debt 317B 207M 181M 167M 157M 294M 19.52B 300M 2.01B 778M 9.65B 777M 760M 33.45B 351B 229M 200M 185M 173M 324M 21.56B 331M 2.22B 859M 10.66B 858M 839M 36.95B
Logo HANDOK Inc.
HANDOK Inc. is a Korea-based company engaged in the manufacture and marketing of pharmaceuticals. The Company's products include Amaryl for diabetes; Tritace for hypertension, myocardial infarction, heart failure and other cardiovascular diseases; Teveten and Triapin for essential hypertension; Munobal for hypertension and stenocardia; Ketas for disturbance of cerebral circulation; Lasix for hypertension and edema, and remedies for skin and others. It also provides over-the-counter (OTC) pharmaceuticals, healthcare products, as well as medical devices, diagnostic reagents and vaccines. In addition, the Company is involved in the real estates rental business. On July 26, 2013, it changed its name to HANDOK Inc. from Handok Pharmaceuticals Co., LTD.
Employees
940
Date Price Change Volume
26-06-25 6,700.00 -2.19% 30,639
26-06-25 ₩6,850.00 -2.97% 14,478
26-06-24 ₩7,060.00 +2.02% 23,335
26-06-23 ₩6,920.00 -6.86% 36,756
26-06-22 ₩7,430.00 -3.13% 23,642
  1. Stock Market
  2. Stocks
  3. A002390 Stock